0001193125-26-211988
SEC filingQ1 revenue grew 2.9% to $10.1M with gross margin expansion to 68.2%, narrowing operating and net losses 10.3% and 13.2% respectively through cost discipline, though cash burn persists amid strategic shifts to reduce ad dependence.
The 68.2% gross margin drove a 4.4% YoY gross profit increase to $6.9M on $10.1M revenue, primarily due to a higher average selling price (ASP) from CMS inflationary adjustments on MyoPro billing codes and lower material costs. This pricing power and cost efficiencies demonstrate Myomo's ability to enhance profitability even with modest 2.9% revenue growth. However, higher clinical costs charged to cost of goods sold partially offset these gains, introducing potential volatility tied to direct-to-patient delivery timing under ASC 606. As volume scales, sustained ASP elevation will be key to maintaining this margin level amid clinical expense pressures.
Operating loss improved 10.3% to -$3.2M from -$3.5M, reflecting disciplined cost management. The decrease stemmed primarily from reduced spending on outside consultants and professional fees, alongside lower labor expenses in project management, engineering, and research. These efficiencies narrowed the operating margin to -31.2% while supporting revenue growth. Investors should note this progress signals a path toward breakeven as Myomo pivots to higher-margin channels like MyoConnect referrals, O&P partnerships, and international markets including Germany, aiming to boost operating leverage and lessen reliance on advertising-driven direct-to-patient revenues.
Net loss narrowed 13.2% to -$3.0M with diluted EPS improving to -$0.07 from -$0.08. The improvement in other income, net reflected changes in fair value of derivative liabilities tied to the Avenue term loan, driven by stock price declines and market volatility. Debt issuance costs are being amortized into interest expense using the interest rate method over the loan term. Operationally, efforts continue with the China JV restructuring led by Chinaleaf Capital to restart activities, though success is not assured. These dynamics underscore Myomo's focus on execution amid external variables.